Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Induction of differentiation is a promising therapeutic strategy against acute myeloid leukemia. However, current differentiation therapies are effective only to specific patient populations. To identify novel differentiation agents with wider efficacy, we developed a phenotypic high-throughput screen with a range of genetically diverse cell lines. From the resulting hits, one chemical scaffold was optimized in terms of activity and physicochemical properties to yield OXS007417, a proof-of-concept tool compound, which was also able to decrease tumor volume in a murine in vivo xenograft model.

Original publication

DOI

10.1021/acs.jmedchem.1c00574

Type

Journal article

Journal

J Med Chem

Publication Date

11/11/2021

Volume

64

Pages

15608 - 15628

Keywords

Animals, Antineoplastic Agents, Cell Differentiation, Cell Survival, Dose-Response Relationship, Drug, Drug Screening Assays, Antitumor, Female, Humans, Leukemia, Myeloid, Acute, Male, Mice, Mice, Inbred NOD, Mice, SCID, Molecular Structure, Neoplasms, Experimental, Phenotype, Structure-Activity Relationship, Tumor Cells, Cultured